Regulators are actively encouraging medtech companies to use real-world data and synthetic control arms. Heres why this is ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
News-Medical.Net on MSN
AI language models actually help in digestive disease care
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer: We Must Do Better The treatment options for children with brain tumors are limited, and more clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback